ANDA 85956, held by Watson Labs. Chlorpromazine Hydrochloride.
As of Nov 16, 2026, ANDA 85956 (Chlorpromazine Hydrochloride), held by Watson Labs, was first approved by FDA on Nov 16, 1979, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 16, 1979 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Chlorpromazine Hydrochloride25MG ยท tablet;oral | Chlorpromazine Hydrochloride | Discontinued |
| Apr 19, 1988 | Supplement 20Labeling | Approved | None posted |
| Nov 16, 1979 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters